BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
1-Year Return 36.47%
This Quarter Return
+0.74%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$895M
AUM Growth
+$57.1M
Cap. Flow
+$145M
Cap. Flow %
16.18%
Top 10 Hldgs %
69.58%
Holding
37
New
4
Increased
8
Reduced
2
Closed
4

Top Buys

1
NAMS icon
NewAmsterdam Pharma
NAMS
+$90.5M
2
NTRA icon
Natera
NTRA
+$56.2M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$22.7M
4
SLDB icon
Solid Biosciences
SLDB
+$14M
5
ANNX icon
Annexon
ANNX
+$6.64M

Top Sells

1
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$28.8M
2
DVAX icon
Dynavax Technologies
DVAX
+$16M
3
ARYE
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
+$4.91M
4
BLSA
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
+$4.89M
5
THRD
Third Harmonic Bio
THRD
+$4.85M

Sector Composition

1 Healthcare 99.35%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
XLO icon
26
Xilio Therapeutics
XLO
$37.6M
$7.55M 0.84%
2,805,413
– –
MRNS
27
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$5.7M 0.64%
1,431,058
– –
THRD
28
DELISTED
Third Harmonic Bio
THRD
$4.95M 0.55%
1,151,657
-1,128,425
-49% -$4.85M
NAUT icon
29
Nautilus Biotechnolgy
NAUT
$91.1M
$3.6M 0.4%
2,000,000
– –
IVVD icon
30
Invivyd
IVVD
$226M
$2.91M 0.32%
1,937,207
– –
APTX
31
DELISTED
Aptinyx Inc. Common Stock
APTX
$2.54M 0.28%
8,891,758
– –
SYRE icon
32
Spyre Therapeutics
SYRE
$957M
$2.41M 0.27%
213,908
– –
NAMSW icon
33
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$66.6M
$86K 0.01%
+100,000
New +$86K
AMLX icon
34
Amylyx Pharmaceuticals
AMLX
$1.04B
– –
-1,023,214
Closed -$28.8M
ARYE
35
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
– –
-500,000
Closed -$4.91M
FLACU
36
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
– –
-300,000
Closed -$3.05M
BLSA
37
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
– –
-487,500
Closed -$4.89M
1
2